Literature DB >> 34039011

Beneficial gut microbiome remodeled during intermittent fasting in humans.

Jasmine W Larrick1, Andrew R Mendelsohn2,3, James Larrick4.   

Abstract

Intermittent fasting (IF) is the practice of restricting food intake for 12 to 48 hours per fasting cycle over a prolonged period of time. Previous work shows beneficial health effects such as weight loss and lower risk for cardiometabolic diseases. Although reduced calorie intake may account for some of the observed benefits of intermittent fasting, exact mechanisms are still unclear. Recent evidence indicates that intermittent fasting may lead to remodeling and increased taxonomic diversity in the human gut microbiome. In particular, the Lachnospiraceae family of anaerobic bacteria increased during fasting. This family, in the order Clostridiales, promotes butryogenesis in the gut, a process that is associated with healthful metabolic and prolongevity effects. IF-associated alterations to the microbiome may play a key role in the metabolic and potential healthspan-enhancing benefits of IF and dietary restriction.

Entities:  

Year:  2021        PMID: 34039011     DOI: 10.1089/rej.2021.0025

Source DB:  PubMed          Journal:  Rejuvenation Res        ISSN: 1549-1684            Impact factor:   4.663


  4 in total

1.  Temporal relationship among adiposity, gut microbiota, and insulin resistance in a longitudinal human cohort.

Authors:  Kui Deng; Menglei Shuai; Zheqing Zhang; Zengliang Jiang; Yuanqing Fu; Luqi Shen; Ju-Sheng Zheng; Yu-Ming Chen
Journal:  BMC Med       Date:  2022-05-19       Impact factor: 11.150

2.  Influence of Aging, Macronutrient Composition and Time-Restricted Feeding on the Fischer344 x Brown Norway Rat Gut Microbiota.

Authors:  Abbi R Hernandez; Keri M Kemp; Sara N Burke; Thomas W Buford; Christy S Carter
Journal:  Nutrients       Date:  2022-04-22       Impact factor: 5.717

3.  Association of food insecurity on gut microbiome and metabolome profiles in a diverse college-based sample.

Authors:  Alex E Mohr; Paniz Jasbi; Kiley B Vander Wyst; Irene van Woerden; Xiaojian Shi; Haiwei Gu; Corrie M Whisner; Meg Bruening
Journal:  Sci Rep       Date:  2022-08-23       Impact factor: 4.996

Review 4.  Role of Intermittent Fasting in the Management of Prediabetes and Type 2 Diabetes Mellitus.

Authors:  Tioluwani K Ojo; Olajide O Joshua; Oboseh J Ogedegbe; Oluwapelumi Oluwole; Ayoade Ademidun; Damilola Jesuyajolu
Journal:  Cureus       Date:  2022-09-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.